Semler Scientific, Inc.
SMLRNASDAQHealthcare
$20.33
$-1.04(-4.87%)
Market Cap$310745920
P/E Ratio—
52W High$65.98
52W Low$14.885
Semler Scientific, Inc. (SMLR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SMLR · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $56.29M | $68.18M | $56.69M | $53.03M | $38.60M |
| Cost of Revenue | $4.76M | $6.98M | $4.25M | $6.12M | $3.36M |
| Gross Profit | $51.53M | $61.20M | $52.43M | $46.91M | $35.25M |
| Gross Margin %(computed) | 91.55% | 89.76% | 92.50% | 88.45% | 91.31% |
| Operating Expenses | |||||
| R&D Expenses | $4.79M | $5.77M | $4.81M | $3.78M | $2.94M |
| G&A Expenses | $12.73M | $14.29M | $12.74M | $9.23M | $6.41M |
| Total Operating Expenses | $30.60M | $38.94M | $35.23M | $27.46M | $19.29M |
| Operating Income | $20.93M | $22.26M | $17.20M | $19.45M | $15.96M |
| Operating Margin %(computed) | 37.19% | 32.64% | 30.35% | 36.67% | 41.35% |
| Interest Income | $1.88M | $2.47M | $0.49M | $0.01M | $0.02M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | $47.88M | $24.10M | $17.69M | $19.45M | $16.49M |
| Income Tax Expense | $6.99M | $3.52M | $3.37M | $2.23M | $2.48M |
| Net Income | $40.90M | $20.58M | $14.32M | $17.22M | $14.01M |
| Net Margin %(computed) | 72.65% | 30.19% | 25.27% | 32.48% | 36.28% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $5.66 | $3.06 | $2.13 | $2.56 | $2.13 |
| Wtd Avg Shares | 7.23M | 6.73M | 6.73M | 6.73M | 6.58M |
| EBITDA | $21.51M | $23.59M | $17.79M | $20.08M | $17.06M |
| EBITDA Margin %(computed) | 38.21% | 34.60% | 31.39% | 37.86% | 44.20% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Semler Scientific, Inc. data
About Semler Scientific, Inc. (SMLR) Income Statement
Semler Scientific, Inc. (SMLR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, SMLR reported revenue of $0.06B, gross profit of $0.05B (gross margin 91.55%), and net income of $0.04B — a net profit margin of 72.65%.
Frequently asked questions
SMLR · 4 questionsSemler Scientific, Inc. (SMLR) reported revenue of $0.06B for 2024, down 17.4% year-over-year.
SMLR revenueSMLR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08